Skip to main content

Peer Review reports

From: Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study

Original Submission
14 Nov 2023 Submitted Original manuscript
16 Nov 2023 Reviewed Reviewer Report - Wei Wang
25 Nov 2023 Reviewed Reviewer Report
14 Dec 2023 Author responded Author comments - Arne May
20 Dec 2023 Author responded Author comments - Arne May
Resubmission - Version 2
14 Dec 2023 Submitted Manuscript version 2
Publishing
21 Dec 2023 Editorially accepted
9 Jan 2024 Article published 10.1186/s10194-023-01709-8

You can find further information about peer review here.

Back to article page